No­vo takes on gut-brain ax­is dis­cov­ery with Kally­ope, fo­cus­ing on obe­si­ty and di­a­betes

As the phar­ma gi­ant push­es to keep its pipeline rel­e­vant, No­vo Nordisk has inked yet an­oth­er part­ner­ship — this time, with gut-brain ax­is com­pa­ny Kally­ope. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER